


\multicolumn{1}{|c|}{ } & \multicolumn{1}{c|}{ } & \multicolumn{1}{c|}{ } & \multicolumn{2}{c|}{Ochalek (2018)} & \multicolumn{2}{c|}{Woods (2016)} & \multicolumn{2}{c|}{P-Rivi√®re (2023)} \\
\cline{4-5} \cline{6-7} \cline{8-9}
Comparison & Number of evaluations & Study decision & High & Low & High & Low & High & Low\\
\hline
PCV7 vs NoVax & 24 & 83\% & 50\% & 45\% & 50\% & 15\% & 62\% & 46\%\\
\hline
PCV10 vs NoVax & 74 & 89\% & 62\% & 45\% & 53\% & 12\% & 69\% & 42\%\\
\hline
PCV13 vs NoVax & 61 & 89\% & 62\% & 57\% & 63\% & 32\% & 67\% & 51\%\\
\hline
PCV13 vs PCV10 & 27 & 78\% & 69\% & 62\% & 68\% & 56\% & 67\% & 59\%\\
\hline
Others & 10 & 90\% & 75\% & 75\% & 80\% & 50\% & 75\% & 75\%\\
\hline
All comparisons & 196 & 87\% & 62\% & 52\% & 59\% & 27\% & 68\% & 49\%\\
\hline

